Free Trial

LifeStance Health Group (LFST) Competitors

LifeStance Health Group logo
$7.29 +0.24 (+3.40%)
(As of 12/20/2024 05:31 PM ET)

LFST vs. HIMS, GH, OPCH, SHC, VCYT, BTSG, SGRY, CON, PRVA, and ARDT

Should you be buying LifeStance Health Group stock or one of its competitors? The main competitors of LifeStance Health Group include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), Sotera Health (SHC), Veracyte (VCYT), BrightSpring Health Services (BTSG), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), and Ardent Health Partners (ARDT). These companies are all part of the "healthcare" industry.

LifeStance Health Group vs.

LifeStance Health Group (NASDAQ:LFST) and Hims & Hers Health (NYSE:HIMS) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, valuation, institutional ownership, risk, media sentiment, community ranking, earnings, dividends and profitability.

Hims & Hers Health received 28 more outperform votes than LifeStance Health Group when rated by MarketBeat users. Likewise, 38.61% of users gave Hims & Hers Health an outperform vote while only 26.19% of users gave LifeStance Health Group an outperform vote.

CompanyUnderperformOutperform
LifeStance Health GroupOutperform Votes
11
26.19%
Underperform Votes
31
73.81%
Hims & Hers HealthOutperform Votes
39
38.61%
Underperform Votes
62
61.39%

LifeStance Health Group has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.25, suggesting that its share price is 25% more volatile than the S&P 500.

85.5% of LifeStance Health Group shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 6.6% of LifeStance Health Group shares are owned by insiders. Comparatively, 17.7% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Hims & Hers Health has higher revenue and earnings than LifeStance Health Group. LifeStance Health Group is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeStance Health Group$1.21B2.31-$186.26M-$0.26-28.04
Hims & Hers Health$1.24B4.61-$23.55M$0.4459.55

LifeStance Health Group currently has a consensus price target of $8.70, suggesting a potential upside of 19.34%. Hims & Hers Health has a consensus price target of $22.80, suggesting a potential downside of 12.98%. Given LifeStance Health Group's higher probable upside, equities analysts plainly believe LifeStance Health Group is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeStance Health Group
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Hims & Hers Health
1 Sell rating(s)
8 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.41

Hims & Hers Health has a net margin of 8.19% compared to LifeStance Health Group's net margin of -7.90%. Hims & Hers Health's return on equity of 10.97% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeStance Health Group-7.90% -6.66% -4.51%
Hims & Hers Health 8.19%10.97%8.29%

In the previous week, Hims & Hers Health had 22 more articles in the media than LifeStance Health Group. MarketBeat recorded 29 mentions for Hims & Hers Health and 7 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 0.62 beat Hims & Hers Health's score of 0.48 indicating that LifeStance Health Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeStance Health Group
2 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hims & Hers Health
11 Very Positive mention(s)
5 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral

Summary

Hims & Hers Health beats LifeStance Health Group on 14 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LFST vs. The Competition

MetricLifeStance Health GroupHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$2.79B$867.07M$5.12B$9.07B
Dividend YieldN/A1.90%4.91%4.22%
P/E Ratio-28.0432.2091.3417.19
Price / Sales2.313.751,116.59116.80
Price / CashN/A25.1442.6437.86
Price / Book1.932.924.794.78
Net Income-$186.26M-$5.79M$120.07M$225.60M
7 Day Performance1.67%-4.93%-1.89%-1.24%
1 Month Performance-0.27%-4.89%11.45%3.36%
1 Year Performance-4.08%226.77%30.61%16.58%

LifeStance Health Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LFST
LifeStance Health Group
1.6908 of 5 stars
$7.29
+3.4%
$8.70
+19.3%
-0.3%$2.79B$1.21B-28.049,325Positive News
Gap Up
HIMS
Hims & Hers Health
3.3819 of 5 stars
$31.01
+3.3%
$21.43
-30.9%
+214.3%$6.78B$872M70.251,046Analyst Forecast
Insider Trade
News Coverage
GH
Guardant Health
4.115 of 5 stars
$35.15
+1.1%
$40.60
+15.5%
+25.6%$4.34B$692.26M-8.201,779
OPCH
Option Care Health
4.8671 of 5 stars
$23.41
-0.3%
$30.14
+28.8%
-29.9%$3.98B$4.78B19.747,802Positive News
SHC
Sotera Health
3.5856 of 5 stars
$13.00
-1.1%
$16.08
+23.7%
-20.0%$3.68B$1.05B52.603,000Positive News
VCYT
Veracyte
4.0331 of 5 stars
$43.51
+0.7%
$41.13
-5.5%
+49.0%$3.37B$361.05M-288.13790Positive News
BTSG
BrightSpring Health Services
2.312 of 5 stars
$19.03
+2.5%
$18.50
-2.8%
N/A$3.31B$10.59B-71.3835,000Analyst Forecast
SGRY
Surgery Partners
3.2423 of 5 stars
$22.16
+8.8%
$36.56
+65.0%
-33.8%$2.82B$2.74B-46.2913,500
CON
Concentra Group Holdings Parent
N/A$21.54
+5.1%
$28.50
+32.3%
N/A$2.74B$1.88B0.0011,000Gap Up
PRVA
Privia Health Group
2.8961 of 5 stars
$21.81
+4.1%
$24.80
+13.7%
-12.6%$2.62B$1.66B209.621,102
ARDT
Ardent Health Partners
N/A$16.83
+0.8%
$21.82
+29.6%
N/A$2.40B$5.71B0.0024,200Analyst Forecast
Positive News

Related Companies and Tools


This page (NASDAQ:LFST) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners